A 3546 New Jersey General Assembly · 2024-2025 Regular Session

Requires insurers and SHBP to provide coverage for expenses incurred in screening for ovarian cancer.

This bill requires all health insurers, health maintenance organizations (HMOs), and the State Health Benefits Program in New Jersey to cover medically necessary ovarian cancer screening for women with symptoms or at higher risk. Specifically, it mandates coverage for annual pelvic exams, ultrasounds, and blood tests (like CA-125 markers) as part of routine screening. The law applies to all individual, group, small employer, and state-purchased health plans issued or renewed after its effective date. This ensures consistent access to these diagnostic services without additional cost to patients who qualify under the specified criteria.
Bill status in committee 1 of 4 stages cleared
Introduction
Feb 2024
Committee Review
Floor Vote
Governor
Introduced Feb 5, 2024 Last action Mar 20, 2025
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
3
Key actions
0
Committee
2
Mar 20, 2025
Committee
Reported and Referred to Assembly Financial Institutions and Insurance Committee
lower
Mar 20, 2025
Committee
Transferred to Assembly Health Committee
lower
Feb 5, 2024
Introduced
Introduced in the Assembly, Referred to Assembly Financial Institutions and Insurance Committee
lower
3 primary · 4 co-sponsors

Sponsors